MediciNova, Inc. Profile Avatar - Palmy Investing

MediciNova, Inc.

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inf…

Biotechnology
US, La Jolla [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of MNOV's Analysis
CIK: 1226616 CUSIP: 58468P206 ISIN: US58468P2065 LEI: - UEI: -
Secondary Listings
MNOV has no secondary listings inside our databases.